Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Garcia

Showing results (201-210 of 317) with videos related to

Pageof 32
Sort By:
Immunity|November 22, 2011
T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complexJarrett J Adams, Samanthi Narayanan, Baoyu Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease TherapyJamie B Spangler, Eleonora Trotta, Jakub Tomala, et al.
JCI Insight|September 5, 2023
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2Brendan L Horton, Alicia D D'Souza, Maria Zagorulya, et al.
Nature|March 12, 2026
Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonistQinli Sun, Alison K Barrett, Masato Ogishi, et al.
Nature Communications|February 8, 2022
Mesenchymal-epithelial crosstalk shapes intestinal regionalisation via Wnt and Shh signallingMartti Maimets, Marianne Terndrup Pedersen, Jordi Guiu, et al.
Nature|March 1, 2019
Structure of the IFNγ receptor complex guides design of biased agonistsJuan L Mendoza, Nichole K Escalante, Kevin M Jude, et al.
Elife|August 23, 2017
Deconstruction of the beaten Path-Sidestep interaction network provides insights into neuromuscular system developmentHanqing Li, Ash Watson, Agnieszka Olechwier, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 5, 2026
Corrigendum to "IL-34 exacerbates pathogenic features of Alzheimers disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice" [Biomed. Pharmacother. 166 (2023) 115435]Anny Ho, Bidii Ngala, Chiaki Yamada, et al.
Science (New York, N.Y.)|June 1, 2013
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodiesKipp Weiskopf, Aaron M Ring, Chia Chi M Ho, et al.
Cell|August 23, 2011
Structural linkage between ligand discrimination and receptor activation by type I interferonsChristoph Thomas, Ignacio Moraga, Doron Levin, et al.
Pageof 32

Showing results (201-210 of 317) with videos related to

Sort By:
Pageof 32
Immunity|November 22, 2011
T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complexJarrett J Adams, Samanthi Narayanan, Baoyu Liu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 2018
Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease TherapyJamie B Spangler, Eleonora Trotta, Jakub Tomala, et al.
JCI Insight|September 5, 2023
Overcoming lung cancer immunotherapy resistance by combining nontoxic variants of IL-12 and IL-2Brendan L Horton, Alicia D D'Souza, Maria Zagorulya, et al.
Nature|March 12, 2026
Facile induction of immune tolerance by an interleukin-2-TGFβ surrogate agonistQinli Sun, Alison K Barrett, Masato Ogishi, et al.
Nature Communications|February 8, 2022
Mesenchymal-epithelial crosstalk shapes intestinal regionalisation via Wnt and Shh signallingMartti Maimets, Marianne Terndrup Pedersen, Jordi Guiu, et al.
Nature|March 1, 2019
Structure of the IFNγ receptor complex guides design of biased agonistsJuan L Mendoza, Nichole K Escalante, Kevin M Jude, et al.
Elife|August 23, 2017
Deconstruction of the beaten Path-Sidestep interaction network provides insights into neuromuscular system developmentHanqing Li, Ash Watson, Agnieszka Olechwier, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 5, 2026
Corrigendum to "IL-34 exacerbates pathogenic features of Alzheimers disease and calvaria osteolysis in triple transgenic (3x-Tg) female mice" [Biomed. Pharmacother. 166 (2023) 115435]Anny Ho, Bidii Ngala, Chiaki Yamada, et al.
Science (New York, N.Y.)|June 1, 2013
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodiesKipp Weiskopf, Aaron M Ring, Chia Chi M Ho, et al.
Cell|August 23, 2011
Structural linkage between ligand discrimination and receptor activation by type I interferonsChristoph Thomas, Ignacio Moraga, Doron Levin, et al.
Pageof 32